An interventional study of brief intervention following alcohol screening and brief intervention following alcohol screening in Alcohol Use Disorder, sponsored by HBSA. Completed at 2 sites in 2 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-21.
Sponsored by HBSA · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to compare two different strategies to deliver brief interventions to people whose scores on the Alcohol Use Disorders Identification Test (AUDIT) suggest that their level of alcohol use may be unhealthy. Brief interventions typically seek to increase the awareness of people whose alcohol use may be unhealthy of the extent and potential adverse consequences of their substance use, and then to provide guidance and motivate them to reduce their consumption. Due to limitations in the use of traditional brief interventions delivered face-to-face by health care providers, applications have been developed to support the electronic delivery of brief interventions. The main question posed in this study is: Is an electronic brief intervention (eBI) delivered via an app on a handheld device at least as effective in reducing alcohol consumption as a traditional in-person brief intervention delivered by a facilitator, who is a trained health educator? We expect that eBI will not be significantly less effective than face-to-face brief intervention.
To test the efficacy of eBI compared to traditional in-person brief intervention, researchers will compare changes in average 30-day quantity and frequency of drinking alcohol, AUDIT scores, and in several additional measures of outcomes related to risky or hazardous alcohol use between participants who received an eBI and those who received a face-to-face brief intervention. In this non-inferiority trial, the intervention (i.e., electronic brief intervention via an app) will be considered effective if it yields reductions in participants' risky or hazardous alcohol use that are no less than those produced by the comparison condition (i.e., a traditional brief intervention through an in-person interaction).
Participants will:
Background and Study Purpose
As is well-documented by the World Health Organization (WHO), alcohol abuse remains a major health hazard worldwide, responsible for 5.3 percent of all deaths annually. It also contributes to over 200 conditions related to disease and injury, which include an array of behavioral and mental health disorders. There is now a substantial body of literature suggesting the effectiveness of Screening and Brief Intervention (SBI) as a strategy to identify people at high risk for alcohol use disorder, and to invite them, within the context of a short motivational interview, to reflect on their drinking patterns and develop a realistic and achievable plan to reduce their consumption. The screening component of SBI typically relies on the Alcohol Use Disorders Identification Test (AUDIT), which comprises two parts. The first is a 3-item assessment (the AUDIT-C); individuals who score 8 or higher are then invited to: (1) respond to 7 additional questions about their alcohol consumption (the AUDIT-7) and (2) participate in a brief intervention that is typically conducted by their primary health care provider or a staff member.
There are a variety of reasons, however, why brief interventions may fail to fulfill expectations of their positive effects. Eligible participants may be reluctant to engage fully in brief interventions because of the stigma attached to doing so; and primary health care providers may lack the time, attention, and confidence in their ability to conduct the brief intervention, or delegate responsibility for its administration to staff members who are insufficiently trained to deliver the intervention as intended, which includes establishing a sufficient rapport with the participant.
Consideration has thus been given to strategies to automate the delivery of brief interventions so that they can be self-administered electronically. Prototypes of this delivery mechanism are under development, and are sufficiently far advanced that they warrant investigations of their effectiveness. The key research question to be addressed by this study is:
Note that the study's purpose is not to determine whether the administration of brief interventions via a handheld device is superior to that of an in-person administration, but to investigate whether the two modes of delivery are at least of equal effectiveness.
Study Setting
This study will be conducted in communities in two low- and middle-income countries: Zacatecas, Mexico and Alexandra Township, South Africa. In each site approximately seven to nine hospitals and health care clinics will participate in the study.
Institutional Recruitment Procedures
A country-specific study contractor will recruit the hospitals and clinics where the SBI will be delivered. All participating institutions will express their willingness to permit the contractor's trained facilitators (health educators) to approach patients in waiting areas and administer the AUDIT screening tool to them via an electronic device. For those patients who score 8 or higher on the AUDIT-C, the institutions will agree to:
Study Participant Requirements and Procedures
All patients who are at least 18 years old and score 8 or above on the AUDIT will be eligible and recruited for the study as long as they have not been screened in the past six months. They will be informed of their eligibility via the consent language presented in the app after the screening and before the study survey (those who do not qualify for the study do not see the consent language or the survey but go directly from the screening to their brief intervention). Specifically, the consent form on the device will inform them that:
Study Sample
All screened patients who are are aged 18 or older, who score 8 or higher on the AUDIT, and who have not been screened in the past 6 months will be eligible to participate in the study. Initial targets were to enroll 460 participants (230 in each brief intervention condition or study arm) in each country. At this point, Mexico has enrolled 563 participants (289 traditional BI; 274 electronic BI). Baseline data collection is still ongoing in South Africa.
Analysis Plan
In this non-inferiority trial, the null hypothesis is that the intervention (i.e., a BI delivered electronically via an app) is inferior to the comparison (i.e., an in-person brief intervention, or business as usual). This would be reflected in a statistically significant greater reduction in drinking alcohol post-intervention among those receiving an in-person BI compared to those receiving an electronic BI.
1,674 studies on the registry are indexed under Alcoholism; 331 are open to participants now.
This study's enrollment of 1,439 is above the median of 88 across 1,428 interventional studies indexed under Alcoholism.
Browse Alcoholism studies →HBSA is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive an electronic brief intervention via an app accessed on a handheld device
Behavioral: brief intervention following alcohol screening
Participants receive a face-to-face brief intervention via a personal discussion with a trained facilitator
Behavioral: brief intervention following alcohol screening
Provision of a brief intervention via an electronic app
Provision of a brief intervention via a face-to-face interaction with a trained facilitator
Average daily quantity X frequency within last 30 days
In the past 30 days, on how many days did you have a whole drink, more than a sip or taste, of any alcoholic beverage? In the past 30 days, on the days when you drank alcohol, about how many whole drinks did you typically have?
Time frame: 3 months and 6 months
Maximum quantity x frequency within last 30 days
You said you usually had \[Number from Alc 2\] whole drinks when you drank alcohol. Thinking about the past 30 days, what was the greatest number of drinks with alcohol you had on any one day? In the past 30 days, on how many days did you have \[Number from Alc 3\] alcoholic drinks?
Time frame: 3 months and 6 months
30-day frequency of 6+ drinks
On how many days in the past 30 days did you have 6 or more alcoholic drinks on one occasion?
Time frame: 3 months and 6 months
Past 3 months total 10-item AUDIT score
AUDIT-C + AUDIT 7 scores
Time frame: 3 months and 6 months
Plan to share: Yes — All individual participant data held by this study's investigators will be made available to other researchers following the conclusion of this study. Note that all data will be fully deidentified.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: All data will be made available within six months following the publication of a manuscript detailing the study's main findings. These data will be available indefinitely.
Access criteria: All data will be made available to interested researchers upon written request to the GSDG Data Library. The GSDG Data Library is an independent, external warehouse designed to help advance knowledge, science, and the field of public health by making all data sourced in the pursuit of the Global Smart Drinking Goals initiative available for scientific use. HBSA, the external evaluator of the GSDG Initiative, oversees the collection, coordination, measurement, and evaluation of all data collected as well as its analysis and assessment. Scientific researchers can apply to access GSDG Data Library data to replicate evaluation results, conduct their own research, and plan programs to reduce harmful alcohol consumption
Data sharing details ↗ · gsdgdatalibrary.org
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.